Insulin is the most commonly used second-line antihyperglycemic drug for patients with poor glycemic control [32] Furthermore, previous studies have reported that the duration of DM and glycemic control are related to the development of NAF [33–36]. This evidence concerns the gene INS and diabetes mellitus.